Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions

Cancer Immunology, Immunotherapy

Volumn 57, Issue 7, 2008, Pages 951-961

  Mulligan, Jennifer K ^a   Lathers, Deanne M R ^a,b   Young, M Rita I ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Endothelial cell; Immune suppression; Lewis lung carcinoma; Suppressor; Tumor

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BIOASSAY; CD8+ T LYMPHOCYTE; CELL DISRUPTION; CELL FUNCTION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXPOSURE; FEMALE; IMMUNOMODULATION; IMMUNOSTIMULATION; LEWIS CARCINOMA; LYMPHOCYTE FUNCTION; MACROPHAGE; MACROPHAGE FUNCTION; MEDIATOR; MOUSE; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE; TUMOR CELL;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; ENDOTHELIAL CELLS; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, INBRED C57BL; PHAGOCYTOSIS; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 42649090829     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0425-x     Document Type: Article

References (30)

1. Barker LP (2006) Mycobacterium leprae interactions with the host cell: recent advances. Indian J Med Res 123:748-759
2. Berg M, Wingender G, Djandji D, Hegenbarth S, Momburg F, Hammerling G, Limmer A, Knolle P (2006) Cross-presentation of antigens from apoptotic tumor cells by liver sinusoidal endothelial cells leads to tumor-specific CD8+ T cell tolerance. Eur J Immunol 36:2960-2970
3. Briscoe DM, Henault LE, Geehan C, Alexander SI, Lichtman AH (1997) Human endothelial cell costimulation of T cell IFN-gamma production. J Immunol 159:3247-3256
4. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S et al (1997) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med 10:942-949
5. Danese S, Dejana E, Fiocchi C (2007) Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 178:6017-6022
6. Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39(9):531-536
7. Elgert KD, Alleva DG, Mullins DW (1998) Tumor-induced immune dysfunction: the macrophage connection. J Leukoc Biol 64:275-290
8. Finke J, Ferrone S, Frey A, Mufson A, Ochoa A (1999) Where have all the T cells gone? Mechanisms of immune evasion by tumors. Immunol Today 20:158-160
9. Gallia GL, Tamargo RJ (2006) Leukocyte-endothelial cell interactions in chronic vasospasm after subarachnoid hemorrhage. Neurol Res 28:750-758
10. Leek RD, Harris AL (2002) Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 7:177-189
11. Lizee G, Radvanyi LG, Overwijk WW, Hwu P (2006) Improving antitumor immune responses by circumventing immunoregulatory. Cells Mech 12:4794-4803
12. Katz SC, Pillarisetty VG, Bleier JI, Shah AB, DeMatteo RP (2004) Liver sinusoidal endothelial cells are insufficient to activate T cells. J Immunol 173:230-235
13. Kindle L, Rothe L, Kriss M, Osdoby P, Collin-Osdoby P (2006) Human microvascular endothelial cell activation by IL-1 and TNF-α stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional. Osteoclasts 21:193-206
14. Konur A, Kreutz M, Knuchel R, Krause SW, Andreesen R (1996) Three-dimensional co-culture of human monocytes and macrophages with tumor cells: analysis of macrophage differentiation and activation. Int J Cancer 66:645-652
15. Krupnick AS, Gelman AE, Barchet W, Richardson S, Kreisel FH, Turka LA, Colonna M, Patterson GA, Kreisel D (2005) Murine vascular endothelium activates and induces the generation of allogeneic CD4 + 25+Foxp3+ regulatory T cells. J Immunol 175:6265-6270
16. Lefkowitz DL, Roberts E, Grattendick K, Schwab C, Stuart R, Lincoln J, Allen RC, Moguilevsky N, Bollen A, Lefkowitz SS (2000) The endothelium and cytokine secretion: the role of peroxidases as immunoregulators. Cell Immunol 202(1):23-30
17. Lejeune P, Lagadec P, Onier N, Pinard D, Ohshima H, Jeannin JF (1994) Nitric oxide involvement in tumor-induced immunosuppression. J Immunol 152:5077-5083
18. Lienenluke B, Germann T, Kroczek RA, Hecker M (2000) CD154 stimulation of interleukin-12 synthesis in human endothelial cells. Eur J Immunol 30:2864-2870
19. Ma W, Pober JS (1998) Human endothelial cells effectively costimulate cytokine production by, but not differentiation of, naive CD4+ T cells. J Immunol 161:2158-2167
20. Mantovani A, Schioppa T, Porta C, Allavena P, Sica A (2006) Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 25(3):315-322
21. Mitsuhashi M, Liu J, Cao S, Shi X, Ma X (2004) Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas. J Leulock Biol 76(2):322-332
22. Nazareth MR, Broderick L, Simpson-Abelson MR, Kelleher RJ Jr, Yokota SJ, Bankert RB (2007) Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 178:5552-5562
23. Ohira H, Abe K, Yokokawa J, Takiguchi J, Rai T, Shishido S, Sato Y (2003) Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J Med Sci 49:1-13
24. Ohm JE, Gabrilovich DI, Sempowski GD, Sempowski E, Parman KS, Nadaf S, Carbone DP (2003) VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101:4878-4886
25. Papamichail M, Perez S, Gritzapis A, Baxevanis C (2004) Natural killer lymphocytes: biology, development and function. Cancer Immunol Immunother 53:176-186
26. Pirtskhalaishvili G, Nelson JB (2000) Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 44:77-87
27. Pockaj BA, Basu GD, Pathangey LB, Gray RJ, Hernandez JL, Gendler SJ, Mukherjee P (2004) Reduced T-cell and dendritic cell function is related to cyclooxygenase-2 overexpression and prostaglandin E2 secretion in patients with breast cancer. Ann Surg Oncol 11(3):328-339
28. Rodig N, Ryan T, Allen JA, Pang H, Grabie N, Chernova T, Greenfield EA, Liang SC, Sharpe AH, Lichtman AH, Freeman GJ (2003) Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33:3117-126
29. Young MR (2004) Trials and tribulations of immunotherapy as a treatment option for patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 53:375-382
30. Young MR, Wright MA, Matthews JP, Malik I, Prechel M (1996) Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide. J Immunol 156:1916-1922